Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis-Reference-Cited by-同舟云学术

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis

Published:2019-07 Issue:8 Volume:17 Page:1525-1532.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Colombel Jean-Frédéric,Adedokun Omoniyi J.,Gasink Christopher,Gao Long-Long^ORCID,Cornillie Freddy J.,D'Haens Geert R.,Rutgeerts Paul J.,Reinisch Walter,Sandborn William J.,Hanauer Stephen B.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group;Targan;N Engl J Med,1997

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

3. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial;Hanauer;Gastroenterology,2006

4. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial;Sandborn;Gut,2007

5. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM Trial;Colombel;Gastroenterology,2007

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy;Internal Medicine Journal;2024-09-05

2. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12

3. Positioning Crohn’s Disease Therapies in the Era of Small Molecules and Combination Therapies;Current Gastroenterology Reports;2024-07-06

4. DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering;Digestive Diseases and Sciences;2024-07-04

5. IBD Matchmaking - Rational Combination Therapy;Clinical Gastroenterology and Hepatology;2024-07